Silverarc Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Silverarc Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-88,243	Closed	-$1.89M	–	105
2022 Q4	$1.89M	Sell	88,243 -89,121	-50%	-$1.9M	0.54%	55
2022 Q3	$3.18M	Buy	+177,364	New	+$2.33M	1.08%	31
2021 Q4	–	Sell	-30,000	Closed	-$487K	–	90
2021 Q3	$487K	Buy	+30,000	New	+$326K	0.28%	68
2021 Q2	–	Sell	-130,043	Closed	-$804K	–	121
2021 Q1	$804K	Hold	130,043	–	–	0.44%	59
2020 Q4	$899K	Buy	+130,043	New	+$832K	0.52%	53

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Silverarc Capital Management's ISEE Position: Q1 2023 in Review

Silverarc Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 88,243 shares — an estimated $1.89M sold.

Silverarc Capital Management first reported a position in ISEE in Q4 2020 and held it in 5 quarters. The position peaked at $3.18M in Q3 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Silverarc Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Silverarc Capital Management sold 88,243 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $1.89M.
Silverarc Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Silverarc Capital Management's IVERIC bio, Inc. Common Stock position peaked at $3.18M in Q3 2022.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Silverarc Capital Management's 13F filing for Q1 2023, filed 15 May 2023.